| |
|
|
|
Clovis Oncology Inc.  
|
|
6.61 -0.08 (-0.01%) |
07-02 16:00 |
|
Open: |
6.77 |
Pre close: |
6.69 |
Target:
|
8.45
|
|
High: |
6.8334 |
Low: |
6.49 |
Resistance:
|
7.24
7.75
|
|
Volume: |
3,339,402 |
Market Cap: |
582M |
Support:
|
6.41
5.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.82
 |
MACD |
MACD(12,26):
|
-0.16 |
|
MA(20): |
7.04  |
Signal(12,26,9): |
-0.14 |
|
MA(100): |
7.38 |
Stochastic Oscillator |
%K(14,3):
|
21.67 |
|
MA(250): |
7.59 |
%D(3): |
30.83 |
|
Average Volume(K) |
3-Month: |
691734
|
52-Week |
High:
|
17.37 |
|
10-Days: |
533352 |
Low: |
2.93 |
|
RSI |
RSI(14):
|
42.30 |
Change(%): |
-53.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-7.060 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
87.99 |
|
EPS Est. Current Year |
-7.580 |
Return on Assets (ttm) |
-32.8 |
Shares Float (M) |
69.72 |
|
EPS Est. Next Year |
-2.460 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.27 |
|
EPS Est. Next Quarter |
-1.150 |
Qtrly Rev. Growth |
28.5 |
% Held by Institutions |
48.46 |
|
Forward EPS |
-7.430 |
Gross Profit (p.s.) |
1.285 |
Shares Short (K) |
26060 |
|
Book Value (p.s.) |
-1.730 |
EBITDA (p.s.) |
-4.045 |
P/E |
-0.94 |
|
Sales Per Share |
1.733 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-3.82 |
|
Profit Margin |
-271.13 |
Operating Cash Flow
(M) |
-307.66 |
P/S |
3.82 |
|
Operating Margin |
-238.84 |
Levered Free Cash Flow
(M) |
-152.20 |
P/CF |
-1.89 |
|
|
|
|
|
|
